Action 1875 TOT BIOPHARM INTERNATIONAL COMPANY LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues TOT BIOPHARM International Company Limited

Actions

1875

HK0000545266

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:09:09 25/04/2024 		Varia. 5j. Varia. 1 janv.
1,58 HKD +4,64 % Graphique intraday de TOT BIOPHARM International Company Limited +3,95 % -19,80 %
15/03 TOT BIOPHARM International Company Limited annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 La perte de TOT Biopharm se réduit au premier semestre MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
TOT Biopharm's Loss Narrows in January-September Period
TOT Biopharm's Loss Narrows in H1
TOT BIOPHARM International Company Limited Announces Directorate and Committee Changes
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
TOT BIOPHARM's Q1 Loss Widens Despite Higher Revenue
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
TOT Biopharm Terminates Phase 3 Trial of Breast Cancer Drug; Shares Fall 5%
TOT BIOPHARM International Company Limited Announces Termination of Phase III Clinical Trial Study and Development of Taa013
TOT BIOPHARM’s Production Base for Antibody Drug Receives Good Manufacturing Report from Europe
TOT BIOPHARM International Company Limited Announces Change of Address of Registered Office
TOT Biopharm International Logs Reduction in H1 Net Loss; Shares Climb 3%
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOP BIOPHARM Shares
TOT BIOPHARM International Company Limited announced that it expects to receive HKD 110 million in funding from Center Laboratories, Inc.
TOT Biopharm Narrows Loss on Lower Selling, R&D Expenses in 2021
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
TOT BIOPHARM International Company Limited Announces Change of Directors and Change of Composition of Board Committees
China Approves New Indications for TOT Biopharm's Cancer Drug
TOT BIOPHARM International Company Limited Announces Change of Joint Company Secretary and Finance Personnel
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 1875
  4. Actualités TOT BIOPHARM International Company Limited
  5. Autres langues